2 Result(s)

Article

Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia

T(8;21)(q22;q22.1)/AML1-ETO positive acute myeloid leukemia (AE-AML) is sensitive to conventional chemotherapy with a favorable prognosis. However, recent small case reports suggest the limited effectiveness o...

Zhao Yin, Zurong Yao, Dandan Chen, Yu Zhang… in Journal of Cancer Research and Clinical On… (2024)

Article

Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study

Dan Xu, Ying Yang, Zhao Yin, Sanfang Tu, Danian Nie, Yiqing Li… in Blood Cancer Journal (2023)